A microbe scribbling its own DNA to chase market curves? Imagine it copying a new gene each time the price hits a threshold, then using that code as a predictive algorithm—like a living spreadsheet that updates in real time. It’d be a messy, high‑mutation experiment, probably blowing up in a Petri dish before it gets to the stock exchange. But if it worked, the next ticker would be a series of ATCG patterns, and traders would need to learn the language of plasmids. In short, bio‑market‑gaming, but with a lot more pipettes and less coffee.